Alcohol Use Disorder Clinical Trial
Official title:
Effects of Acute Exercise on Psychological, Physiological, Biochemical and Alcohol-related Parameters in Individuals With Alcohol Use Disorders
Verified date | January 2016 |
Source | University of Thessaly |
Contact | n/a |
Is FDA regulated | No |
Health authority | Greece: Ethics Committee |
Study type | Interventional |
The purpose of this research is to examine the effects of exercise of different intensities on psychological, physiological, biochemical, physiological and alcohol-related parameters in individuals with alcohol use disorders (heavy drinkers and alcoholic patients) in order to investigate possible biochemical mechanisms by which exercise may be a healthy alternative to alcohol abuse. For that purpose, a control group of individuals that do not exceed the limits for moderate alcohol use will be included.
Status | Completed |
Enrollment | 13 |
Est. completion date | June 2014 |
Est. primary completion date | March 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
For alcoholics: Inclusion Criteria: - Confirmed alcohol addiction according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria in the past, after detoxification phase, lack of dependence on other substances - Alcohol Use Disorders Identification Test (AUDIT) score>20 Exclusion Criteria: - Medical conditions or medication use that would preclude participation in aerobic exercise For heavy drinkers: Inclusion Criteria: - Men drinking >14 drinks/week or >4 drinks/occasion; Women drinking >7 drinks/week or >4 drinks/occasion (1 drink = 14 grams of pure alcohol; definition of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for drinking at low risk for developing an AUD; NIAAA, 2014) - Individuals drinking 5 or more drinks on the same occasion on each of 5 or more days in the past 30 days (1 drink = 14 grams of pure alcohol; definition of the Substance Abuse and Mental Health Services Administration for heavy drinking; NIAAA, 2014) - AUDIT score>8 Exclusion Criteria: - Medical conditions or medication use that would preclude participation in aerobic exercise For healthy controls: Inclusion Criteria: - Men drinking <14 drinks/week or <4 drinks/occasion; Women drinking <7 drinks/week or <4 drinks/occasion (1 drink = 14 grams of pure alcohol; definition of the NIAAA for drinking at low risk for developing an AUD; NIAAA, 2014) - Individuals drinking <5 drinks on the same occasion on each of 5 or more days in the past 30 days (1 drink = 14 grams of pure alcohol; definition of the Substance Abuse and Mental Health Services Administration for heavy drinking; NIAAA, 2014) - AUDIT score<8 Exclusion Criteria: - Medical conditions or medication use that would preclude participation in aerobic exercise |
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Thessaly | European Social Fund |
Georgakouli K, Manthou E, Fatouros IG, Deli CK, Spandidos DA, Tsatsakis AM, Kouretas D, Koutedakis Y, Theodorakis Y, Jamurtas AZ. Effects of acute exercise on liver function and blood redox status in heavy drinkers. Exp Ther Med. 2015 Dec;10(6):2015-2022. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in Urge to drink score | According to questionnaire | Before (0 min) and after exercise trial (30 min) | No |
Primary | Changes in Beta-endorphin levels | Measured by radioimmunoassay (RIA) | Before (0 min) and after exercise trial (30 min) | No |
Primary | Changes in Cortisol levels | Measured by radioimmunoassay (RIA) | Before (0 min) and after exercise trial (30 min) | No |
Primary | Changes in Adrenocorticotrophic hormone (ACTH) levels | Measured by radioimmunoassay (RIA) | Before (0 min) and after exercise trial (30 min) | No |
Primary | Changes in Catecholamines (epinephrine, norepinephrine, dopamine) levels | Measured by radioimmunoassay (RIA) | Before (0 min) and after exercise trial (30 min) | No |
Primary | Changes in C-reactive protein (CRP) levels | Semi-quantitative estimation with CRP Latex test kit | Before (0 min) and after exercise trial (30 min) | No |
Primary | Changes in Complete blood count values | Autoanalyzer | Before (0 min) and after exercise trial (30 min) | No |
Primary | Changes in Lactic acid levels | Measured using photometry | Before (0 min) and after exercise trial (30 min) | No |
Primary | Changes in Erythrocyte sedimentation rate (ESR) values | Wintrobe Method | Before (0 min) and after exercise trial (30 min) | No |
Primary | Changes in ?-Glutamyltransferase (GGT) levels | Measured with commercial kit | Before (0 min) and after exercise trial (30 min) | No |
Primary | Changes in Aspartate Aminotransferase (AST) levels | Measured with commercial kit | Before (0 min) and after exercise trial (30 min) | No |
Primary | Changes in Alanine Aminotransferase (ALT) levels | Measured with commercial kit | Before (0 min) and after exercise trial (30 min) | No |
Secondary | Sit and reach flexibility test for the hamstrings muscles and lower back | Each participant sits on the floor with legs stretched out straight ahead, reaches out and holds that position for at 1-2 seconds while the distance is recorded. | Before trial (baseline) | No |
Secondary | Grip strength | Handgrip strength test | Before trial (baseline) | No |
Secondary | Number of push-ups performed in one minute | Before trial (baseline) | No | |
Secondary | Number of sit-ups performed until exhaustion | Before trial (baseline) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04788004 -
Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse
|
||
Recruiting |
NCT05684094 -
Mechanisms of Risky Alcohol Use in Young Adults: Linking Sleep to Reward- and Stress-Related Brain Function
|
N/A | |
Completed |
NCT03406039 -
Testing the Efficacy of an Online Integrated Treatment for Comorbid Alcohol Misuse and Emotional Problems
|
N/A | |
Completed |
NCT03573167 -
Mobile Phone-Based Motivational Interviewing in Kenya
|
N/A | |
Completed |
NCT04817410 -
ED Initiated Oral Naltrexone for AUD
|
Phase 1 | |
Active, not recruiting |
NCT04267692 -
Harm Reduction Talking Circles for American Indians and Alaska Natives With Alcohol Use Disorders
|
N/A | |
Completed |
NCT03872128 -
The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders
|
Phase 1 | |
Completed |
NCT02989662 -
INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers
|
Phase 1/Phase 2 | |
Recruiting |
NCT06030154 -
Amplification of Positivity for Alcohol Use
|
N/A | |
Active, not recruiting |
NCT05419128 -
Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19
|
N/A | |
Completed |
NCT04564807 -
Testing an Online Insomnia Intervention
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT04203966 -
Mental Health and Well-being of People Who Seek Help From Their Member of Parliament
|
||
Recruiting |
NCT05861843 -
Craving Assessment in Patients With Alcohol Use Disorder Using Virtual Reality Exposure
|
||
Terminated |
NCT04404712 -
FAAH Availability in Psychiatric Disorders: A PET Study
|
Early Phase 1 | |
Enrolling by invitation |
NCT04128761 -
Decreasing the Temporal Window in Individuals With Alcohol Use Disorder
|
N/A | |
Not yet recruiting |
NCT06444243 -
Psilocybin-assisted Therapy for Alcohol Use Disorder
|
Phase 2 | |
Not yet recruiting |
NCT06337721 -
Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults
|
N/A | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Enrolling by invitation |
NCT02544581 -
Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare
|
N/A |